Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ViroMissile, Inc.
Tizona Therapeutics, Inc
Innate Pharma
NeoTX Therapeutics Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Eli Lilly and Company
Columbia University
Theratechnologies
National Cancer Institute (NCI)
Eli Lilly and Company
Vincerx Pharma, Inc.
NGM Biopharmaceuticals, Inc
Pfizer
NGM Biopharmaceuticals, Inc
Sierra Oncology LLC - a GSK company
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Ludwig Institute for Cancer Research
PACT Pharma, Inc.
Imperial College London
MacroGenics
MacroGenics
Abramson Cancer Center at Penn Medicine
Celgene
University of Wisconsin, Madison
Viralytics
Threshold Pharmaceuticals
Santa Maria Biotherapeutics
Roswell Park Cancer Institute
University of Southern California
M.D. Anderson Cancer Center
BIND Therapeutics
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
ImmunoFrontier, Inc.
Bristol-Myers Squibb
Life Molecular Imaging SA
University of Chicago
Calando Pharmaceuticals
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)